HealthStream, Inc. $HSTM Stake Cut by Integrated Quantitative Investments LLC

Integrated Quantitative Investments LLC cut its holdings in shares of HealthStream, Inc. (NASDAQ:HSTM) by 75.4% in the third quarter, HoldingsChannel reports. The fund owned 10,200 shares of the technology company’s stock after selling 31,226 shares during the quarter. Integrated Quantitative Investments LLC’s holdings in HealthStream were worth $288,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in HSTM. JPMorgan Chase & Co. lifted its position in shares of HealthStream by 302.0% in the second quarter. JPMorgan Chase & Co. now owns 247,905 shares of the technology company’s stock worth $6,860,000 after purchasing an additional 186,231 shares in the last quarter. Qube Research & Technologies Ltd increased its stake in HealthStream by 77.3% in the 2nd quarter. Qube Research & Technologies Ltd now owns 251,953 shares of the technology company’s stock valued at $6,972,000 after buying an additional 109,883 shares during the period. Bank of America Corp DE lifted its position in HealthStream by 56.2% in the 2nd quarter. Bank of America Corp DE now owns 141,282 shares of the technology company’s stock worth $3,909,000 after buying an additional 50,852 shares in the last quarter. Jane Street Group LLC acquired a new stake in shares of HealthStream during the 1st quarter valued at $1,532,000. Finally, Assenagon Asset Management S.A. acquired a new stake in shares of HealthStream during the 3rd quarter valued at $1,264,000. Institutional investors and hedge funds own 69.58% of the company’s stock.

Insider Buying and Selling

In other news, CTO Jeff Cunningham sold 2,100 shares of the business’s stock in a transaction on Wednesday, December 10th. The shares were sold at an average price of $24.09, for a total value of $50,589.00. Following the completion of the sale, the chief technology officer directly owned 31,489 shares in the company, valued at approximately $758,570.01. The trade was a 6.25% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Kevin P. O’hara sold 2,000 shares of the company’s stock in a transaction on Monday, December 8th. The stock was sold at an average price of $24.26, for a total transaction of $48,520.00. Following the sale, the executive vice president directly owned 16,373 shares of the company’s stock, valued at approximately $397,208.98. This represents a 10.89% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 20.50% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on HSTM. Canaccord Genuity Group set a $25.00 price objective on HealthStream in a report on Thursday, January 8th. Wall Street Zen lowered HealthStream from a “buy” rating to a “hold” rating in a research report on Saturday, November 22nd. Weiss Ratings upgraded HealthStream from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday. Finally, Citigroup reissued a “market perform” rating on shares of HealthStream in a research note on Tuesday, January 6th. Three research analysts have rated the stock with a Hold rating, According to data from MarketBeat, HealthStream currently has a consensus rating of “Hold” and a consensus target price of $25.00.

HealthStream Price Performance

NASDAQ HSTM opened at $21.89 on Friday. HealthStream, Inc. has a fifty-two week low of $19.50 and a fifty-two week high of $34.13. The stock’s 50-day moving average is $21.58 and its two-hundred day moving average is $24.66. The firm has a market cap of $649.48 million, a P/E ratio of 35.89, a price-to-earnings-growth ratio of 2.43 and a beta of 0.45.

HealthStream (NASDAQ:HSTM) last released its quarterly earnings results on Monday, February 23rd. The technology company reported $0.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.16 by $0.02. The company had revenue of $79.71 million during the quarter, compared to the consensus estimate of $76.21 million. HealthStream had a return on equity of 5.98% and a net margin of 6.03%. On average, equities analysts expect that HealthStream, Inc. will post 0.63 EPS for the current year.

HealthStream declared that its board has authorized a stock repurchase program on Tuesday, November 11th that allows the company to buyback $10.00 million in shares. This buyback authorization allows the technology company to reacquire up to 1.3% of its shares through open market purchases. Shares buyback programs are often a sign that the company’s board believes its shares are undervalued.

HealthStream Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, March 20th. Shareholders of record on Monday, March 9th will be issued a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.6%. This is a boost from HealthStream’s previous quarterly dividend of $0.03. The ex-dividend date is Monday, March 9th. HealthStream’s dividend payout ratio is 19.67%.

About HealthStream

HealthStream, Inc is a Nashville, Tennessee–based provider of workforce development and learning management solutions for healthcare organizations. Since its founding in 1990, the company has focused on helping hospitals, clinics and other care providers streamline staff training, ensure regulatory compliance and monitor employee performance. HealthStream’s platform integrates online courses, skill competency assessments and credential management tools to support workforce readiness across the healthcare continuum.

The company’s core offerings include a learning management system (LMS) designed specifically for clinical and nonclinical personnel, a competency management suite that tracks skill acquisition and validation, and a content library featuring evidence-based clinical and compliance training modules.